Watch on demand

Leveraging real world data for assessing and prioritizing market opportunities

The commercialization process for a new therapy is long, complex and expensive. For biopharma companies, this process typically takes 10-15 years. For medical device companies, the process is somewhat shorter, taking between 3 and 7 years. In either case, the process is extremely expensive, the total cost to successfully bring a therapy to market is consistently estimated to be more than $2 billion dollars. This is why it’s crucial for pre-commercial organizations to have the data they need to prioritize their portfolio and development opportunities, secure future financing, and align on product strategy.

In this webinar we’ll cover of on how you can use Latitude Discovery to:

  • Find new opportunities through the ability to iteratively analyze market opportunity across therapies
  • Utilizing a single source of truth for real world evidence across departments
  • Inform programmatic decision making by leveraging real-world data to gain detailed insight into additional clinical attributes associated with your target patient cohort.

Presenter bios:

Mike Sigmon

Mike Sigmon

Mike Sigmon leads a sales team at Definitive Healthcare specializing in Life Sciences and the diagnostic space. He has been involved in analyzing healthcare data for 6 years, and has worked in the SaaS industry for 10 years. He holds a BA in Economics from the University of Kentucky.

 

 

David Kronfeld

David Kronfeld

As Definitive Healthcare's Chief Growth Officer, David oversees the company's corporate development and pricing and focuses on driving growth through a variety of transformation activities. He is a strategic and operational leader with over two decades of experiences in Life Sciences. His past companies include: PatientFinder, Medidata Solutions, and McKinsey&Company.

 

Watch on demand

Explore our data